Registration Options

Activity Dates: 04/26/2022 - 04/26/2025

AAPP 2022 registration is closed.

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

Symptoms of psychosis, including visual hallucinations and delusions, occur in up to 90% of patients with Parkinson’s Disease (PD), Parkinson’s Disease dementia (PDD), and dementia with Lewy bodies (DLB). The theme across these disorders includes the presence of alpha-synuclein pathology, and the pathophysiologic impact on converging brain networks. Identifying and managing these symptoms of psychosis represent a considerable challenge. Therapeutic limitations arise from the paucity of efficacious agents, deterioration in motor function due to dopamine receptor antagonism from conventional antipsychotics, interaction of sleep dysfunction and psychosis presentation, among other factors. As the management of psychosis can be complicated, many of these patients may seek specialized neuropsychiatric care; thus, psychiatric and neurologic pharmacists should be familiar with treatment strategies and pharmacotherapy utilized based on patient diagnosis.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Describe clinical presentation of Parkinson’s Disease (PD), PD dementia (PDD), and dementia with Lewy bodies (DLB).
  2. Discuss prevalence and qualitative information related to psychosis in PD, dementia with Lewy bodies, and other atypical parkinsonian syndromes.
  3. Identify treatment strategies to manage psychotic symptoms in relationship to safety, efficacy, and currently available evidence.
  4. Outline information related to pimavanserin and its suggested indication for management of psychosis in dementia-related psychosis.

Continuing Education Credit and Disclosures

Activity Dates: 04/26/2022 - 04/26/2025
ACPE Contact Hours: 1
ACPE Number: 0284-0000-22-050-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.